Literature DB >> 21476942

Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury.

Shuang-Shuang Dai1, Yuan-Guo Zhou.   

Abstract

This review summarizes recent developments that have contributed to our understanding of how adenosine 2A receptors (A2ARs) modulate brain damage in various animal models of acute neurological injuries, including brain ischemia, traumatic brain injury, spinal cord injury and hemorrhage stroke. The main conclusions are: (1) pharmacological, neurochemical and molecular/genetic approaches to the complex actions of A2AR in different cellular elements suggest that A2AR activation exerts bidirectional effect (detrimental or protective) after brain insults; (2) modulation of glutamate excitotoxicity and neuroinflammation are involved in the protection of A2AR agonists or antagonists, but the bidirectional effect of A2AR is largely due to the bidirectional regulation of neuroinflammation (anti-inflammation or proinflammation) by A2AR on immune cells such as microglia cells and peripheral bone marrow cells; and (3) the bidirectional effect of A2AR on neuroinflammation and brain injury depends on the distinct and sometimes opposite actions of A2AR in various cellular elements and on different injury models and associated pathological conditions. The local glutamate level in the brain injury is one of the crucial factors that contribute to the direction of A2AR effect on neuroinflammation and brain injury outcome. These developments presented here clearly highlight the complexity of using A2AR agents therapeutically in acute neuronal injuries and confirm that A2AR ligands have many promising characteristics that encourage the pursuit of their full therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21476942     DOI: 10.1515/RNS.2011.020

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  26 in total

1.  Adenosine: a fundamental factor formed from Fatty feasts for fighting fits?

Authors:  Jong M Rho
Journal:  Epilepsy Curr       Date:  2012-01       Impact factor: 7.500

2.  2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors.

Authors:  Elizabeth A Newell; Jennifer L Exo; Jonathan D Verrier; Travis C Jackson; Delbert G Gillespie; Keri Janesko-Feldman; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2014-11-03       Impact factor: 3.252

Review 3.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 4.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 5.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

Review 6.  The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.

Authors:  Elham Safarzadeh; Farhad Jadidi-Niaragh; Morteza Motallebnezhad; Mehdi Yousefi
Journal:  Inflamm Res       Date:  2016-03-09       Impact factor: 4.575

7.  Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Delbert G Gillespie; Keri Janesko-Feldman; Rashmi Bansal; Sandra Goebbels; Klaus-Armin Nave; Patrick M Kochanek; Edwin K Jackson
Journal:  Glia       Date:  2013-08-06       Impact factor: 7.452

8.  Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.

Authors:  Darren J Lee; Andrew W Taylor
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

9.  RNA-Sequencing Analysis Revealed a Distinct Motor Cortex Transcriptome in Spontaneously Recovered Mice After Stroke.

Authors:  Masaki Ito; Markus Aswendt; Alex G Lee; Shunsuke Ishizaka; Zhijuan Cao; Eric H Wang; Sabrina L Levy; Daniel L Smerin; Jennifer A McNab; Michael Zeineh; Christoph Leuze; Maged Goubran; Michelle Y Cheng; Gary K Steinberg
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

10.  Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling.

Authors:  Lisa C Loram; Frederick R Taylor; Keith A Strand; Jacqueline A Harrison; Rachael Rzasalynn; Paige Sholar; Jayson Rieger; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2013-06-28       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.